Financing ·
Instinct Bio Technical Company Holdings Inc. announced on July 28, 2026, that it has entered into an indicative term…
BIOTInstinct Bio Technical Co Holdings Inc.
Instinct Bio Technical Company Holdings Inc. announced on July 28, 2026, that it has entered into an indicative term sheet for a proposed equity purchase facility allowing the sale of up to US$150 million of common stock over three years. The facility provides the company with the right, but not the obligation, to direct share purchases based on volume-weighted average price less a specified discount. Proceeds are intended to accelerate the development of its regenerative medicine platform, fund working capital, and pursue strategic acquisitions. This transaction is not yet finalized and depends on executing definitive documents and satisfying conditions. Instinct Bio is a biotechnology company focused on regenerative medicine, longevity-related technologies, and advanced therapeutic platforms.